<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01173107</url>
  </required_header>
  <id_info>
    <org_study_id>Colchicine_2010_1</org_study_id>
    <nct_id>NCT01173107</nct_id>
  </id_info>
  <brief_title>A Pilot Study for PK/PD Parameter of Colchicine in Chronic Kidney Disease Patient.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      A pilot study for PK/PD parameter of colchicine in Chronic kidney disease patient.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum colchicine level</measure>
    <time_frame>0,1,6 hours</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>MDRD eGFR 10~50 ml/min/1.73m2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>colchicine</intervention_name>
    <description>colchicine 1T tid</description>
    <arm_group_label>MDRD eGFR 10~50 ml/min/1.73m2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  from 18yrs to 80yrs , man and women&#xD;
&#xD;
          -  the patient who are taking colchicine&#xD;
&#xD;
          -  On screening, the patient shows that MDRD GFR &gt;= 10 ml/min and &lt;= 50 ml/min&#xD;
&#xD;
          -  the patient sign on the concent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  the patient have experience to take medication that have an effect on renal function&#xD;
&#xD;
          -  At least, the average level of two separate blood pressure ( 2min interval ) shows&#xD;
             that SBP &lt;= 100 mmHg or &gt;=160 mmHg and DBP &lt;=60 mmHg &gt;=100 mmHg, or Heart rate &lt; 40&#xD;
             beats/min or &gt; 90 beats/min&#xD;
&#xD;
          -  pregnancy or anticipate pregnancy with 6 month&#xD;
&#xD;
          -  hypersensitivity to colchicine&#xD;
&#xD;
          -  acute hepatitis or the level of AST or ALT is over 2times of normal range or the level&#xD;
             of bilirubin is over 2.0 mg/dL&#xD;
&#xD;
          -  serum albumin &lt; 3.5 mg/dL or &gt; 5mg/dL&#xD;
&#xD;
          -  urinary retension, prostatic hyperplasia&#xD;
&#xD;
          -  the patient show gout attack on taking colchicine&#xD;
&#xD;
          -  the patient who have gastro-intestinal disease ( ex, crohn's disease, acute or chronic&#xD;
             pancreatitis, ulcer )or who have the surgical history of gastrointestine.&#xD;
&#xD;
          -  the patient who should take Atazanavir, Amprenavir, Apreptant, clarithromycin,&#xD;
             indinavir, itraconazole, ketoconazole, nefazodone, nelfinavir, ritonavir, saquinavir,&#xD;
             telithromycin, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice,&#xD;
             verapamil, cyclosporine, ranolazine&#xD;
&#xD;
          -  the patient who had taken part in the other study within 3months&#xD;
&#xD;
          -  the patient who had gotten blood transfusion&#xD;
&#xD;
          -  pregnant, breast feeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <study_first_submitted>July 28, 2010</study_first_submitted>
  <study_first_submitted_qc>July 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2010</study_first_posted>
  <last_update_submitted>December 27, 2010</last_update_submitted>
  <last_update_submitted_qc>December 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 29, 2010</last_update_posted>
  <responsible_party>
    <name_title>Suhnggwon Kim</name_title>
    <organization>Seoul National University Hospital</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colchicine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

